Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Williamson, DJ; Hargreaves, RJ
   Neurogenic inflammation in the context of migraine
   MICROSCOPY RESEARCH AND TECHNIQUE
   
   D.J. Williamson e R.J. Hargreaves, "Neurogenic inflammation in the context of migraine", MICROSC RES, 53(3), 2001, pp. 167-178
2. Harrison, T; Owens, AP; Williams, BJ; Swain, CJ; Williams, A; Carlson, EJ; Rycroft, W; Tattersall, FD; Cascieri, MA; Chicchi, GG; Sadowski, S; Rupniak, NMJ; Hargreaves, RJ
   An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration
   JOURNAL OF MEDICINAL CHEMISTRY
   
   T. Harrison et al., "An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration", J MED CHEM, 44(24), 2001, pp. 4296-4299
3. Williamson, DJ; Hill, RG; Shepheard, SL; Hargreaves, RJ
   The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs
   BRITISH JOURNAL OF PHARMACOLOGY
   
   D.J. Williamson et al., "The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs", BR J PHARM, 133(7), 2001, pp. 1029-1034
4. Williamson, DJ; Shepheard, SL; Cook, DA; Hargreaves, RJ; Hill, RG; Cumberbatch, MJ
   Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats
   BRITISH JOURNAL OF PHARMACOLOGY
   
   D.J. Williamson et al., "Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats", BR J PHARM, 133(6), 2001, pp. 807-814
5. Silberstein, SD; Hargreaves, RJ
   The history and pharmacology of ergotamine and dihydroergotamine
   DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
   
   S.D. Silberstein e R.J. Hargreaves, "The history and pharmacology of ergotamine and dihydroergotamine", MG CLIN NEU, 17, 2000, pp. 52-65
6. Hargreaves, RJ; Longmore, J; Beer, M; Shepheard, S; Cumberbatch, M; Williamson, D; Stanton, J; Razzaque, Z; Sohal, B; Street, L; Seabrook, G; Hill, R
   The pharmacology and mechanisms of action of rizatriptan
   DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
   
   R.J. Hargreaves et al., "The pharmacology and mechanisms of action of rizatriptan", MG CLIN NEU, 17, 2000, pp. 141-161
7. Hargreaves, RJ
   Pharmacology and potential mechanisms of action of rizatriptan
   CEPHALALGIA
   
   R.J. Hargreaves, "Pharmacology and potential mechanisms of action of rizatriptan", CEPHALALGIA, 20, 2000, pp. 2-9
8. Ma, QP; Hargreaves, RJ
   Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats
   NEUROSCIENCE
   
   Q.P. Ma e R.J. Hargreaves, "Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats", NEUROSCIENC, 101(3), 2000, pp. 699-707
9. Tattersall, FD; Rycroft, W; Cumberbatch, M; Mason, G; Tye, S; Williamson, DJ; Hale, JJ; Mills, SG; Finke, PE; MacCoss, M; Sadowski, S; Ber, E; Cascieri, M; Hill, RG; MacIntyre, DE; Hargreaves, RJ
   The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L758,298, inhibit acute and delayed cisplatin-inducedemesis in ferrets
   NEUROPHARMACOLOGY
   
   F.D. Tattersall et al., "The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L758,298, inhibit acute and delayed cisplatin-inducedemesis in ferrets", NEUROPHARM, 39(4), 2000, pp. 652-663
10. Goadsby, PJ; Hargreaves, RJ
    Mechanisms of action of serotonin 5-HT1B/1D agonists: Insights into migraine pathophysiology using rizatriptan
    NEUROLOGY
    
    P.J. Goadsby e R.J. Hargreaves, "Mechanisms of action of serotonin 5-HT1B/1D agonists: Insights into migraine pathophysiology using rizatriptan", NEUROLOGY, 55(9), 2000, pp. S8-S14
11. Hargreaves, RJ; Shepheard, SL
    Pathophysiology of migraine - New insights
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    R.J. Hargreaves e S.L. Shepheard, "Pathophysiology of migraine - New insights", CAN J NEUR, 26, 1999, pp. S12-S19
12. Cumberbatch, MJ; Williamson, DJ; Mason, GS; Hill, RG; Hargreaves, RJ
    Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M.J. Cumberbatch et al., "Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist", BR J PHARM, 126(6), 1999, pp. 1478-1486
13. Dahlof, CGH; Hargreaves, RJ
    Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?
    CEPHALALGIA
    
    C.G.H. Dahlof e R.J. Hargreaves, "Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?", CEPHALALGIA, 18(9), 1998, pp. 593-604
14. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
    Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses
    CEPHALALGIA
    
    M.J. Cumberbatch et al., "Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses", CEPHALALGIA, 18(10), 1998, pp. 659-663
15. KRAMER MS; CUTLER N; FEIGHNER J; SHRIVASTAVA R; CARMAN J; SRAMEK JJ; REINES SA; LIU GH; SNAVELY D; WYATTKNOWLES E; HALE JJ; MILLS SG; MACCOSS M; SWAIN CJ; HARRISON T; HILL RG; HEFTI F; SCOLNICK EM; CASCIERI MA; CHICCHI GG; SADOWSKI S; WILLIAMS AR; HEWSON L; SMITH D; CARLSON EJ; HARGREAVES RJ; RUPNIAK NMJ
    DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS
    Science
    
    M.S. Kramer et al., "DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS", Science, 281(5383), 1998, pp. 1640-1645
16. WILLIAMSON DJ; CUMBERBATCH MJ; SHEPHEARD SL; HARGREAVES RJ
    SENSITIZATION OF CAUDAL TRIGEMINAL NEURONS BY DURAL ARTERY DILATATION
    Neurology
    
    D.J. Williamson et al., "SENSITIZATION OF CAUDAL TRIGEMINAL NEURONS BY DURAL ARTERY DILATATION", Neurology, 50(4), 1998, pp. 4091-4091
17. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
    The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    M.J. Cumberbatch et al., "The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats", EUR J PHARM, 362(1), 1998, pp. 43-46
18. MAY A; SHEPHEARD SL; KNORR M; EFFERT R; WESSING A; HARGREAVES RJ; GOADSBY PJ; DIENER HC
    RETINAL PLASMA EXTRAVASATION IN ANIMALS BUT NOT IN HUMANS - IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF MIGRAINE
    Brain (Print)
    
    A. May et al., "RETINAL PLASMA EXTRAVASATION IN ANIMALS BUT NOT IN HUMANS - IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF MIGRAINE", Brain (Print), 121, 1998, pp. 1231-1237
19. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
    INTRAVITAL MICROSCOPE STUDIES ON THE EFFECTS OF NEUROKININ AGONISTS AND CALCITONIN-GENE-RELATED PEPTIDE ON DURAL VESSEL DIAMETER IN THE ANESTHETIZED RAT
    Cephalalgia
    
    D.J. Williamson et al., "INTRAVITAL MICROSCOPE STUDIES ON THE EFFECTS OF NEUROKININ AGONISTS AND CALCITONIN-GENE-RELATED PEPTIDE ON DURAL VESSEL DIAMETER IN THE ANESTHETIZED RAT", Cephalalgia, 17(4), 1997, pp. 518-524
20. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
    SUMATRIPTAN INHIBITS NEUROGENIC VASODILATION OF DURAL BLOOD-VESSELS IN THE ANESTHETIZED RAT - INTRAVITAL MICROSCOPE STUDIES
    Cephalalgia
    
    D.J. Williamson et al., "SUMATRIPTAN INHIBITS NEUROGENIC VASODILATION OF DURAL BLOOD-VESSELS IN THE ANESTHETIZED RAT - INTRAVITAL MICROSCOPE STUDIES", Cephalalgia, 17(4), 1997, pp. 525-531
21. SHEPHERD SL; WILLIAMSON DJ; BEER MS; HILL RG; HARGREAVES RJ
    DIFFERENTIAL-EFFECTS OF 5-HT1B 1D RECEPTOR AGONISTS ON NEUROGENIC DURAL PLASMA EXTRAVASATION AND VASODILATION IN ANESTHETIZED RATS/
    Neuropharmacology
    
    S.L. Shepherd et al., "DIFFERENTIAL-EFFECTS OF 5-HT1B 1D RECEPTOR AGONISTS ON NEUROGENIC DURAL PLASMA EXTRAVASATION AND VASODILATION IN ANESTHETIZED RATS/", Neuropharmacology, 36(4-5), 1997, pp. 525-533
22. LONGMORE J; RAZZAQUE Z; SCHOFIELD WN; TAYLOR AA; BROWN MJ; PICKARD J; HILL RG; HARGREAVES RJ
    RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN
    Neurology
    
    J. Longmore et al., "RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN", Neurology, 48(3), 1997, pp. 1133-1133
23. HARGREAVES RJ; WILLIAMSON DJ; HILL RG; SHEPHEARD SL
    RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION - AN INTRAVITAL MICROSCOPE STUDY IN RATS
    Neurology
    
    R.J. Hargreaves et al., "RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION - AN INTRAVITAL MICROSCOPE STUDY IN RATS", Neurology, 48(3), 1997, pp. 1134-1134
24. CUMBERBATCH MJ; MASON GS; HILL RG; HARGREAVES RJ
    TRIGEMINAL NEURONS THAT RECEIVE NONNOCICEPTIVE VIBRISSAL INPUT IN THEANESTHETIZED RAT - EFFECTS OF CONVERGENT NOCICEPTIVE INPUT FROM THE DURA-MATER AND OF A 5-HT1B 1D AGONIST/
    Journal of physiology
    
    M.J. Cumberbatch et al., "TRIGEMINAL NEURONS THAT RECEIVE NONNOCICEPTIVE VIBRISSAL INPUT IN THEANESTHETIZED RAT - EFFECTS OF CONVERGENT NOCICEPTIVE INPUT FROM THE DURA-MATER AND OF A 5-HT1B 1D AGONIST/", Journal of physiology, 504P, 1997, pp. 103-104
25. CUMBERBATCH MJ; HILL RG; HARGREAVES RJ
    RIZATRIPTAN HAS CENTRAL ANTINOCICEPTIVE EFFECTS AGAINST DURALLY EVOKED-RESPONSES
    European journal of pharmacology
    
    M.J. Cumberbatch et al., "RIZATRIPTAN HAS CENTRAL ANTINOCICEPTIVE EFFECTS AGAINST DURALLY EVOKED-RESPONSES", European journal of pharmacology, 328(1), 1997, pp. 37-40
26. WILLIAMSON DJ; SHEPHEARD SL; HILL RG; HARGREAVES RJ
    THE NOVEL ANTIMIGRAINE AGENT RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION AND EXTRAVASATION
    European journal of pharmacology
    
    D.J. Williamson et al., "THE NOVEL ANTIMIGRAINE AGENT RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION AND EXTRAVASATION", European journal of pharmacology, 328(1), 1997, pp. 61-64
27. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; SADOWSKI S; BER E; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; OWEN S; SWAIN CJ; HILL RG; HARGREAVES RJ
    IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS
    European journal of pharmacology
    
    N.M.J. Rupniak et al., "IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS", European journal of pharmacology, 326(2-3), 1997, pp. 201-209
28. LONGMORE J; HILL RG; HARGREAVES RJ
    NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS
    Canadian journal of physiology and pharmacology
    
    J. Longmore et al., "NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS", Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 612-621
29. CUMBERBATCH MJ; HILL RG; HARGREAVES RJ
    RIZATRIPTAN INHIBITS TRIGEMINAL NOCICEPTIVE RESPONSES IN AN ELECTROPHYSIOLOGICAL ASSAY IN THE ANESTHETIZED RAT
    British Journal of Pharmacology
    
    M.J. Cumberbatch et al., "RIZATRIPTAN INHIBITS TRIGEMINAL NOCICEPTIVE RESPONSES IN AN ELECTROPHYSIOLOGICAL ASSAY IN THE ANESTHETIZED RAT", British Journal of Pharmacology, 120, 1997, pp. 213-213
30. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; SWAIN CJ; HILL RG; HARGREAVES RJ
    PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS
    British Journal of Pharmacology
    
    N.M.J. Rupniak et al., "PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS", British Journal of Pharmacology, 120, 1997, pp. 363-363
31. STERNFELD F; BAKER R; BROUGHTON HB; GUIBLIN AR; JELLEY RA; MATASSA VG; REEVE AJ; BEER MS; STANTON JA; HARGREAVES RJ; SHEPHEARD SL; LONGMORE J; RAZZAQUE Z; GRAHAM MI; SOHAL B; STREET LJ
    THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS
    Bioorganic & medicinal chemistry letters
    
    F. Sternfeld et al., "THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS", Bioorganic & medicinal chemistry letters, 6(15), 1996, pp. 1825-1830
32. TATTERSALL FD; RYCROFT W; FRANCIS B; PEARCE D; MERCHANT K; MACLEOD AM; LADDUWAHETTY T; KEOWN L; SWAIN C; BAKER R; CASCIERI M; BER E; METZGER J; MACINTYRE DE; HILL RG; HARGREAVES RJ
    TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS
    Neuropharmacology
    
    F.D. Tattersall et al., "TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS", Neuropharmacology, 35(8), 1996, pp. 1121-1129
33. LADDUWAHETTY T; BAKER R; CASCIERI MA; CHAMBERS MS; HAWORTH K; KEOWN LE; MACINTYRE DE; METZGER JM; OWEN S; RYCROFT W; SADOWSKI S; SEWARD EM; SHEPHEARD SL; SWAIN CJ; TATTERSALL FD; WATT AP; WILLIAMSON DW; HARGREAVES RJ
    N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS
    Journal of medicinal chemistry
    
    T. Ladduwahetty et al., "N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS", Journal of medicinal chemistry, 39(15), 1996, pp. 2907-2914
34. SEABROOK GR; SHEPHEARD SL; WILLIAMSON DJ; TYRER P; RIGBY M; CASCIERI MA; HARRISON T; HARGREAVES RJ; HILL RG
    L-733,060, A NOVEL TACHYKININ NK1 RECEPTOR ANTAGONIST - EFFECTS IN [CA2+](I) MOBILIZATION, CARDIOVASCULAR AND DURAL EXTRAVASATION ASSAYS
    European journal of pharmacology
    
    G.R. Seabrook et al., "L-733,060, A NOVEL TACHYKININ NK1 RECEPTOR ANTAGONIST - EFFECTS IN [CA2+](I) MOBILIZATION, CARDIOVASCULAR AND DURAL EXTRAVASATION ASSAYS", European journal of pharmacology, 317(1), 1996, pp. 129-135
35. LAIRD JMA; MASON GS; WEBB J; HILL RG; HARGREAVES RJ
    EFFECTS OF A PARTIAL AGONIST AND A FULL ANTAGONIST ACTING AT THE GLYCINE SITE OF THE NMDA RECEPTOR ON INFLAMMATION-INDUCED MECHANICAL HYPERALGESIA IN RATS
    British Journal of Pharmacology
    
    J.M.A. Laird et al., "EFFECTS OF A PARTIAL AGONIST AND A FULL ANTAGONIST ACTING AT THE GLYCINE SITE OF THE NMDA RECEPTOR ON INFLAMMATION-INDUCED MECHANICAL HYPERALGESIA IN RATS", British Journal of Pharmacology, 117(7), 1996, pp. 1487-1492
36. MASON GS; TATTERSALL FD; HILL RG; HARGREAVES RJ
    EFFECT OF THE NK1 RECEPTOR ANTAGONISTS, L-733,060 AND CP-99,994, AND MORPHINE IN THE RABBIT SPINAL REFLEX PREPARATION
    British Journal of Pharmacology
    
    G.S. Mason et al., "EFFECT OF THE NK1 RECEPTOR ANTAGONISTS, L-733,060 AND CP-99,994, AND MORPHINE IN THE RABBIT SPINAL REFLEX PREPARATION", British Journal of Pharmacology, 117, 1996, pp. 242-242
37. SHEPHEARD SL; WILLIAMSON DJ; COOK D; HILL RG; HARGREAVES RJ
    STUDIES ON THE SYMPATHOLYTIC EFFECTS OF SOME 5-HT1D RECEPTOR AGONISTSIN PITHED RATS AND GUINEA-PIGS
    British Journal of Pharmacology
    
    S.L. Shepheard et al., "STUDIES ON THE SYMPATHOLYTIC EFFECTS OF SOME 5-HT1D RECEPTOR AGONISTSIN PITHED RATS AND GUINEA-PIGS", British Journal of Pharmacology, 117, 1996, pp. 268-268
38. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
    DIRECT MEASUREMENT OF DURAL BLOOD-VESSEL DIAMETER IN THE RAT USING INTRAVITAL MICROSCOPY
    British Journal of Pharmacology
    
    D.J. Williamson et al., "DIRECT MEASUREMENT OF DURAL BLOOD-VESSEL DIAMETER IN THE RAT USING INTRAVITAL MICROSCOPY", British Journal of Pharmacology, 117, 1996, pp. 271-271
39. LAIRD JMA; MASON GS; THOMAS KA; HARGREAVES RJ; HILL RG
    ACIDIC FIBROBLAST GROWTH-FACTOR STIMULATES MOTOR AND SENSORY AXON REGENERATION AFTER SCIATIC-NERVE CRUSH IN THE RAT
    Neuroscience
    
    J.M.A. Laird et al., "ACIDIC FIBROBLAST GROWTH-FACTOR STIMULATES MOTOR AND SENSORY AXON REGENERATION AFTER SCIATIC-NERVE CRUSH IN THE RAT", Neuroscience, 65(1), 1995, pp. 209-216
40. GILL R; HARGREAVES RJ; KEMP JA
    THE NEUROPROTECTIVE EFFECT OF THE GLYCINE SITE ANTAGONIST 3R-(-CIS-4-METHYL-HA966 (L-687,414) IN A RAT MODEL OF FOCAL ISCHEMIA())
    Journal of cerebral blood flow and metabolism
    
    R. Gill et al., "THE NEUROPROTECTIVE EFFECT OF THE GLYCINE SITE ANTAGONIST 3R-(-CIS-4-METHYL-HA966 (L-687,414) IN A RAT MODEL OF FOCAL ISCHEMIA())", Journal of cerebral blood flow and metabolism, 15(2), 1995, pp. 197-204
41. TAN KKC; BROWN MJ; HARGREAVES RJ; SHEPHERD SL; COOK DA; HILL RG
    CALCITONIN-GENE-RELATED PEPTIDE AS AN ENDOGENOUS VASODILATOR - IMMUNOBLOCKADE STUDIES IN-VIVO WITH AN ANTI-CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL-ANTIBODY AND ITS FAB-'-FRAGMENT
    Clinical science
    
    K.K.C. Tan et al., "CALCITONIN-GENE-RELATED PEPTIDE AS AN ENDOGENOUS VASODILATOR - IMMUNOBLOCKADE STUDIES IN-VIVO WITH AN ANTI-CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL-ANTIBODY AND ITS FAB-'-FRAGMENT", Clinical science, 89(6), 1995, pp. 565-573
42. SHEPHEARD SL; WILLIAMSON DJ; WILLIAMS J; HILL RG; HARGREAVES RJ
    COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS
    Neuropharmacology
    
    S.L. Shepheard et al., "COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS", Neuropharmacology, 34(3), 1995, pp. 255-261
43. TATTERSALL FD; RYCROFT W; MARMONT N; CASCIERI M; HILL RG; HARGREAVES RJ
    ENANTIOSPECIFIC INHIBITION OF EMESIS INDUCED BY NICOTINE IN THE HOUSEMUSK SHREW (SUNCUS-MURINUS) BY THE NEUROKININ(1) (NK1) RECEPTOR ANTAGONIST CP-99,994
    Neuropharmacology
    
    F.D. Tattersall et al., "ENANTIOSPECIFIC INHIBITION OF EMESIS INDUCED BY NICOTINE IN THE HOUSEMUSK SHREW (SUNCUS-MURINUS) BY THE NEUROKININ(1) (NK1) RECEPTOR ANTAGONIST CP-99,994", Neuropharmacology, 34(12), 1995, pp. 1697-1699
44. STREET LJ; BAKER R; DAVEY WB; GUIBLIN AR; JELLEY RA; REEVE AJ; ROUTLEDGE H; STERNFELD F; WATT AP; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ; SOHAL B; GRAHAM MI; MATASSA VG
    SYNTHESIS AND SEROTONERGIC ACTIVITY OF HYL-2-[5-(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL] ETHYLAMINE AND ANALOGS - POTENT AGONISTS FOR 5-HT1D RECEPTORS
    Journal of medicinal chemistry
    
    L.J. Street et al., "SYNTHESIS AND SEROTONERGIC ACTIVITY OF HYL-2-[5-(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL] ETHYLAMINE AND ANALOGS - POTENT AGONISTS FOR 5-HT1D RECEPTORS", Journal of medicinal chemistry, 38(10), 1995, pp. 1799-1810
45. TATTERSALL FD; RYCROFT W; HILL RG; HARGREAVES RJ
    ENANTIOSELECTIVE INHIBITION OF APOMORPHINE-INDUCED EMESIS IN THE FERRET BY THE NEUROKININ(1) RECEPTOR ANTAGONIST CP-99,994
    Neuropharmacology
    
    F.D. Tattersall et al., "ENANTIOSELECTIVE INHIBITION OF APOMORPHINE-INDUCED EMESIS IN THE FERRET BY THE NEUROKININ(1) RECEPTOR ANTAGONIST CP-99,994", Neuropharmacology, 33(2), 1994, pp. 259-260
46. PATEL S; SMITH AJ; CHAPMAN KL; FLETCHER AE; KEMP JA; MARSHALL GR; HARGREAVES RJ; RYECROFT W; IVERSEN LL; IVERSEN SD; BAKER R; SHOWELL GA; BOURRAIN S; NEDUVELIL JG; MATASSA VG; FREEDMAN SB
    BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO
    Molecular pharmacology
    
    S. Patel et al., "BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO", Molecular pharmacology, 46(5), 1994, pp. 943-948
47. LAIRD JMA; MASON GS; THOMAS KA; HARGREAVES RJ; HILL RG
    ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) STIMULATES RAT SCIATIC-NERVE REGENERATION AFTER A CRUSH INJURY
    Journal of physiology
    
    J.M.A. Laird et al., "ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) STIMULATES RAT SCIATIC-NERVE REGENERATION AFTER A CRUSH INJURY", Journal of physiology, 480P, 1994, pp. 160000069-160000069
48. CASTRO JL; BAKER R; GUIBLIN AR; HOBBS SC; JENKINS MR; RUSSELL MGN; BEER MS; STANTON JA; SCHOLEY K; HARGREAVES RJ; GRAHAM MI; MATASSA VG
    SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ETHYL-1,2,5-THIADIAZOLIDIN-2-YL)-METHYL]-1H-INDOLE AND ANALOGS - AGONISTS FOR THE 5-HT1D RECEPTOR
    Journal of medicinal chemistry
    
    J.L. Castro et al., "SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ETHYL-1,2,5-THIADIAZOLIDIN-2-YL)-METHYL]-1H-INDOLE AND ANALOGS - AGONISTS FOR THE 5-HT1D RECEPTOR", Journal of medicinal chemistry, 37(19), 1994, pp. 3023-3032
49. TAN KKC; BROWN MJ; HARGREAVES RJ; SHEPHEARD SL; COOK DA; HILL RG
    CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AS AN ENDOGENOUS VASODILATOR -IN-VIVO IMMUNOBLOCKADES STUDIES WITH AN ANTI-CGRP MONOCLONAL-ANTIBODYAND ITS FAB' FRAGMENT
    British Journal of Pharmacology
    
    K.K.C. Tan et al., "CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AS AN ENDOGENOUS VASODILATOR -IN-VIVO IMMUNOBLOCKADES STUDIES WITH AN ANTI-CGRP MONOCLONAL-ANTIBODYAND ITS FAB' FRAGMENT", British Journal of Pharmacology, 112, 1994, pp. 210000014-210000014
50. HARGREAVES RJ; HILL RG; IVERSEN LL
    NEUROPROTECTIVE NMDA ANTAGONISTS - THE CONTROVERSY OVER THEIR POTENTIAL FOR ADVERSE-EFFECTS ON CORTICAL NEURONAL MORPHOLOGY
    Acta neurochirurgica
    
    R.J. Hargreaves et al., "NEUROPROTECTIVE NMDA ANTAGONISTS - THE CONTROVERSY OVER THEIR POTENTIAL FOR ADVERSE-EFFECTS ON CORTICAL NEURONAL MORPHOLOGY", Acta neurochirurgica, 1994, pp. 15-19
51. HARGREAVES RJ; RIGBY M; SMITH D; HILL RG; IVERSEN LL
    COMPETITIVE AS WELL AS UNCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS AFFECT CORTICAL NEURONAL MORPHOLOGY AND CEREBRAL GLUCOSE-METABOLISM
    Neurochemical research
    
    R.J. Hargreaves et al., "COMPETITIVE AS WELL AS UNCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS AFFECT CORTICAL NEURONAL MORPHOLOGY AND CEREBRAL GLUCOSE-METABOLISM", Neurochemical research, 18(12), 1993, pp. 1263-1269
52. STREET LJ; BAKER R; CASTRO JL; CHAMBERS MS; GUIBLIN AR; HOBBS SC; MATASSA VG; REEVE AJ; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ
    SYNTHESIS AND SEROTONERGIC ACTIVITY OF 5-(OXADIAZOLYL)TRYPTAMINES - POTENT AGONISTS FOR 5-HT(1D) RECEPTORS
    Journal of medicinal chemistry
    
    L.J. Street et al., "SYNTHESIS AND SEROTONERGIC ACTIVITY OF 5-(OXADIAZOLYL)TRYPTAMINES - POTENT AGONISTS FOR 5-HT(1D) RECEPTORS", Journal of medicinal chemistry, 36(11), 1993, pp. 1529-1538
53. TATTERSALL FD; RYCROFT W; HARGREAVES RJ; HILL RG
    THE TACHYKININ NK(1) RECEPTOR ANTAGONIST CP-99,994 ATTENUATES CISPLATIN-INDUCED EMESIS IN THE FERRET
    European journal of pharmacology
    
    F.D. Tattersall et al., "THE TACHYKININ NK(1) RECEPTOR ANTAGONIST CP-99,994 ATTENUATES CISPLATIN-INDUCED EMESIS IN THE FERRET", European journal of pharmacology, 250(1), 1993, pp. 180000005-180000006
54. BEER MS; STANTON JA; BEVAN Y; HEALD A; REEVE AJ; STREET LJ; MATASSA VG; HARGREAVES RJ; MIDDLEMISS DN
    L-694,247 - A POTENT 5-HT(1D) RECEPTOR AGONIST
    British Journal of Pharmacology
    
    M.S. Beer et al., "L-694,247 - A POTENT 5-HT(1D) RECEPTOR AGONIST", British Journal of Pharmacology, 110(3), 1993, pp. 1196-1200
55. HARGREAVES RJ; RIGBY M; SMITH D; HILL RG
    LACK OF EFFECT OF L-687,414 ((-CIS-4-METHYL-HA-966), AN NMDA RECEPTORANTAGONIST ACTING AT THE GLYCINE SITE, ON CEREBRAL GLUCOSE-METABOLISMAND CORTICAL NEURONAL MORPHOLOGY())
    British Journal of Pharmacology
    
    R.J. Hargreaves et al., "LACK OF EFFECT OF L-687,414 ((-CIS-4-METHYL-HA-966), AN NMDA RECEPTORANTAGONIST ACTING AT THE GLYCINE SITE, ON CEREBRAL GLUCOSE-METABOLISMAND CORTICAL NEURONAL MORPHOLOGY())", British Journal of Pharmacology, 110(1), 1993, pp. 36-42
56. LAIRD JMA; HARGREAVES RJ; HILL RG
    EFFECT OF RP 67580, A NONPEPTIDE NEUROKININ(1) RECEPTOR ANTAGONIST, ON FACILITATION OF A NOCICEPTIVE SPINAL FLEXION REFLEX IN THE RAT
    British Journal of Pharmacology
    
    J.M.A. Laird et al., "EFFECT OF RP 67580, A NONPEPTIDE NEUROKININ(1) RECEPTOR ANTAGONIST, ON FACILITATION OF A NOCICEPTIVE SPINAL FLEXION REFLEX IN THE RAT", British Journal of Pharmacology, 109(3), 1993, pp. 713-718